IN2015DN02930A - - Google Patents
Info
- Publication number
- IN2015DN02930A IN2015DN02930A IN2930DEN2015A IN2015DN02930A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A IN 2930DEN2015 A IN2930DEN2015 A IN 2930DEN2015A IN 2015DN02930 A IN2015DN02930 A IN 2015DN02930A
- Authority
- IN
- India
- Prior art keywords
- luliconazole
- pharmaceutical formulation
- specifying
- establish
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012202696A JP5460797B1 (ja) | 2012-09-14 | 2012-09-14 | アミド誘導体及び安定性指標としてのその使用 |
| PCT/JP2013/055025 WO2014041825A1 (en) | 2012-09-14 | 2013-02-19 | Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02930A true IN2015DN02930A (enrdf_load_html_response) | 2015-09-18 |
Family
ID=47884458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2930DEN2015 IN2015DN02930A (enrdf_load_html_response) | 2012-09-14 | 2013-02-19 |
Country Status (7)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2416758B8 (en) | 2009-04-09 | 2017-10-18 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| WO2010117089A2 (en) | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| KR101806304B1 (ko) | 2010-06-11 | 2017-12-07 | 가부시키가이샤 폴라 파마 | 항진균성 약학적 조성물 |
| EP2895165B1 (en) | 2012-09-14 | 2016-12-14 | Pola Pharma Inc. | Crystal and pharmaceutical preparation containing the same crystal |
| WO2014041708A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5680161B1 (ja) | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5587488B1 (ja) * | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| JP5926756B2 (ja) * | 2014-03-26 | 2016-05-25 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| JP5623671B1 (ja) * | 2014-07-23 | 2014-11-12 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| US10703744B2 (en) * | 2014-12-12 | 2020-07-07 | Glenmark Life Sciences Limited | Process for preparation of luliconazole |
| US12270740B2 (en) * | 2019-02-07 | 2025-04-08 | Shimadzu Corporation | Analysis method, analysis device and non-transitory computer readable recording medium storing program |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3081766B2 (ja) | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| CA2226214C (en) | 1995-07-08 | 2007-04-17 | Nihon Nohyaku Co., Ltd. | Antifungal agent, compound therefor, process for producing the same, and method for using the same |
| JP2002114680A (ja) | 2000-07-31 | 2002-04-16 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
| EP2005959B1 (en) | 2006-03-08 | 2015-01-21 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| WO2007102242A1 (ja) * | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
| EP2025337B1 (en) | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| EP2191828B1 (en) | 2007-09-05 | 2016-08-10 | Pola Pharma Inc. | Antifungal pharmaceutical composition |
| US20100204293A1 (en) | 2007-09-05 | 2010-08-12 | Pola Pharma Inc. | Pharmaceutical composition |
| EP2191827B1 (en) * | 2007-09-05 | 2013-10-30 | Pola Pharma Inc. | Antifungal composition |
| EP2395839B1 (en) | 2009-02-13 | 2014-05-07 | Topica Pharmaceuticals, Inc | Anti-fungal formulation |
| WO2010117089A2 (en) | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2416758B8 (en) | 2009-04-09 | 2017-10-18 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| KR101806304B1 (ko) * | 2010-06-11 | 2017-12-07 | 가부시키가이샤 폴라 파마 | 항진균성 약학적 조성물 |
| EP2895165B1 (en) | 2012-09-14 | 2016-12-14 | Pola Pharma Inc. | Crystal and pharmaceutical preparation containing the same crystal |
| WO2014041708A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| WO2014042043A1 (en) * | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Pharmaceutical composition containing luliconazole |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5587488B1 (ja) * | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
-
2012
- 2012-09-14 JP JP2012202696A patent/JP5460797B1/ja active Active
-
2013
- 2013-02-19 RU RU2015113587A patent/RU2612557C2/ru active
- 2013-02-19 US US14/347,939 patent/US9145401B2/en active Active
- 2013-02-19 IN IN2930DEN2015 patent/IN2015DN02930A/en unknown
- 2013-02-19 CN CN201380047770.5A patent/CN104662017A/zh active Pending
- 2013-02-19 WO PCT/JP2013/055025 patent/WO2014041825A1/en active Application Filing
- 2013-02-19 EP EP13709572.5A patent/EP2895480A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015113587A (ru) | 2016-11-10 |
| RU2612557C2 (ru) | 2017-03-09 |
| JP5460797B1 (ja) | 2014-04-02 |
| CN104662017A (zh) | 2015-05-27 |
| US20150191456A1 (en) | 2015-07-09 |
| EP2895480A1 (en) | 2015-07-22 |
| JP2014058449A (ja) | 2014-04-03 |
| WO2014041825A1 (en) | 2014-03-20 |
| US9145401B2 (en) | 2015-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN02930A (enrdf_load_html_response) | ||
| PH12015501996A1 (en) | Heterocyclic compounds and uses thereof | |
| IN2015MN00405A (enrdf_load_html_response) | ||
| CR20140464A (es) | Compuestos de heterociclilo | |
| CU20140089A7 (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CU20140081A7 (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CU20140095A7 (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| MX2021001231A (es) | Compuestos heterociclicos y sus usos. | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| UA114657C2 (uk) | Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2 | |
| CO7350620A2 (es) | Nuevos derivados de piridina | |
| UY35467A (es) | Compuestos orgánicos | |
| CR20150470A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
| MX2015009719A (es) | Inhibidores benzoquinolona de vmat2. | |
| MX356342B (es) | Agente de control de endoparásitos y método para usarlo. | |
| PH12019501178A1 (en) | Thiopene derivatives as antiviral agents | |
| MY174000A (en) | Novel pyridine derivatives | |
| PH12018502556A1 (en) | Cosmetic base including amide alcohol, and cosmetic | |
| MX2015012416A (es) | Compuestos heterociclicos y sus usos. | |
| CR20150555A (es) | Nuevos derivados de pirrolo[2,3-d]pirimidina | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| IN2015DN00950A (enrdf_load_html_response) | ||
| MX350009B (es) | Derivados de 2-metoxi-piridin-4-ilo. | |
| CY1119984T1 (el) | Σταθεροποιημενη αμορφη μορφη αγομελατινης, μια μεθοδος για την παρασκευη της και φαρμακευτικες συνθεσεις που την περιεχουν | |
| PH12018502555A1 (en) | Cosmetic base including amide alcohol ester, and cosmetic |